Applied BioCode Corporation: Q4 2025 EPS of -NT$1.96
Applied BioCode Corporation announced its Q4 2025 financial results, reporting an EPS of -NT$1.96, revenue of NT$0.475 billion, and a net loss of NT$0.201 billion, indicating significant R&D investment and potential future growth.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 19, 2026 at 03:34 (283h 34m after Collected)
Company Code: 6598
Company Name: Applied BioCode Corporation
Industry: Biotechnology and Healthcare Industry
Year/Quarter: 2025 Q4
Basic Earnings Per Share: -NT$1.96
Operating Revenue: NT$0.475 billion
Net Profit After Tax: -NT$0.201 billion
Company Name: Applied BioCode Corporation
Industry: Biotechnology and Healthcare Industry
Year/Quarter: 2025 Q4
Basic Earnings Per Share: -NT$1.96
Operating Revenue: NT$0.475 billion
Net Profit After Tax: -NT$0.201 billion